We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.3B
AUM Growth
+$229M
Cap. Flow
-$342M
Cap. Flow %
-2.78%
Top 10 Hldgs %
11.52%
Holding
627
New
166
Increased
116
Reduced
155
Closed
161

Sector Composition

Rank Sector Weight
1 Technology 14.15%
2 Healthcare 12.62%
3 Financials 12.54%
4 Industrials 12.05%
5 Consumer Discretionary 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACRS icon
301
Aclaris Therapeutics
ACRS
$813M
$5.75M 0.05%
192,957
+95,103
+97% +$2.74M
BFYT
302
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$5.66M 0.05%
+353,884
New +$6.31M
SNAK
303
DELISTED
Inventure Foods, Inc.
SNAK
$5.64M 0.05%
1,276,652
+210,139
+20% +$1.26M
CHRW icon
304
C.H. Robinson
CHRW
$17.5B
$5.63M 0.05%
72,795
-351,814
-83% -$27M
FBM
305
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$5.54M 0.05%
+346,800
New +$5.58M
V icon
306
Visa
V
$679B
$5.4M 0.04%
60,770
-136,731
-69% -$11.8M
NTRS icon
307
Northern Trust
NTRS
$33.8B
$5.34M 0.04%
61,685
-957,881
-94% -$83.3M
SAGE
308
DELISTED
Sage Therapeutics
SAGE
$5.33M 0.04%
+75,000
New +$4.39M
CLAC
309
CALL
DELISTED
Capitol Acquisition Corp. III
CLAC
$5.28M 0.04%
500,000
BSX icon
310
Boston Scientific
BSX
$71.4B
$5.23M 0.04%
210,199
-2,275,001
-92% -$55.3M
GDS icon
311
GDS Holdings
GDS
$6.44B
$5.22M 0.04%
630,778
+12,578
+2% +$103K
AAP icon
312
Advance Auto Parts
AAP
$3.47B
$5.19M 0.04%
+35,000
New +$5.62M
JILL icon
313
J. Jill
JILL
$277M
$5.09M 0.04%
+86,014
New +$4.68M
TXT icon
314
Textron
TXT
$15.4B
$5.09M 0.04%
106,879
-1,034,540
-91% -$49.9M
VMC icon
315
Vulcan Materials
VMC
$36.9B
$5.04M 0.04%
+41,875
New +$5.12M
FNV icon
316
Franco-Nevada
FNV
$45.7B
$4.92M 0.04%
75,024
-26,176
-26% -$1.69M
XRAY icon
317
Dentsply Sirona
XRAY
$2.44B
$4.91M 0.04%
78,600
-936,907
-92% -$56.4M
ZVRA icon
318
Zevra Therapeutics
ZVRA
$681M
$4.88M 0.04%
62,261
-160
-0.3% -$9.72K
STL
319
DELISTED
Sterling Bancorp
STL
$4.75M 0.04%
+200,450
New +$4.82M
BRX icon
320
Brixmor Property Group
BRX
$9.32B
$4.68M 0.04%
+218,140
New +$5.07M
XYL icon
321
Xylem
XYL
$28.3B
$4.59M 0.04%
91,319
-292,031
-76% -$14.2M
DVN icon
322
Devon Energy
DVN
$47.7B
$4.57M 0.04%
109,479
+75,080
+218% +$3.3M
MCO icon
323
Moody's
MCO
$82.7B
$4.56M 0.04%
40,678
-2,244
-5% -$241K
GIB icon
324
CGI
GIB
$15.4B
$4.52M 0.04%
+94,290
New +$4.52M
SPWH icon
325
Sportsman's Warehouse
SPWH
$46.4M
$4.5M 0.04%
941,450
+416,450
+79% +$2.59M

Similar funds

Alyeska Investment Group's Q1 2017 Portfolio in Review

As of Q1 2017, Alyeska Investment Group held 627 positions worth $12.3B, up 1.9% from $12.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group's Q1 2017 filing shows 166 new, 116 increased, 155 reduced and 161 closed positions. Its largest new stake was Agilent Technologies: 2,378,330 shares worth $126M. The largest sale was Cisco, an estimated $141M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Alyeska Investment Group's largest Q1 2017 buy was Agilent Technologies: 2,378,330 shares worth $126M.
  • Alyeska Investment Group added most to Palo Alto Networks in Q1 2017, an estimated $167M increase.
  • Alyeska Investment Group's biggest Q1 2017 reduction was Cisco, cutting an estimated $141M.
  • Alyeska Investment Group fully exited Stryker in Q1 2017, selling an estimated $134M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12.3B portfolio in Q1 2017.
  • Alyeska Investment Group opened 166 new positions and closed 161 in Q1 2017.
  • Alyeska Investment Group's portfolio value rose 1.9% quarter-over-quarter to $12.3B.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.